Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Mixed Ahead Of Johnson's Brexit Deal Vote

Fri, 20th Dec 2019 12:09

(Alliance News) - Stocks in London were mixed at midday on Friday as investors look ahead to the Brexit deal vote in Parliament in the afternoon, while the UK chancellor finally named a new governor of the Bank of England.

The FTSE 100 index was up 16.90 points, or 0.2% at 7,589.97. The mid-cap FTSE 250 index was down 60.96 points, or 0.3% at 21,605.18, and the AIM All-Share index was 0.4% higher at 941.63.

The Cboe UK 100 index was up 0.2% at 12,865.61. The Cboe 250 was 0.2% lower at 19,518.94, and the Cboe Small Companies was down 0.2% at 12,030.27.

In mainland Europe, the CAC 40 in Paris was up 0.5% and the DAX 30 in Frankfurt was up 0.6%.

"UK stocks are treading water as they eagerly await the next step in the Brexit process today. With Theresa May and Boris Johnson previously unable to pass their respective withdrawal agreements, the value of a strong parliamentary majority will become clear today as Johnson's deal looks set to sail through without a hitch. For markets this should provide some degree of certainty and confidence, yet we are instead seeing anxiety remain thanks to Johnson's hard deadline of December 2020 to conclude trade negotiations," said IG Group's Josh Mahony.

In the FTSE 100, AstraZeneca was up 1.5% after the Anglo-Swedish drugmaker said it divested the rights to cancer drugs Arimidex and Casodex in a number of countries to Juvise Pharmaceuticals for up to USD198 million.

At the other end of the large cap index, NMC Health was by far the worst performer, down 21%. The Financial Times on Friday reported the UAE-focused private healthcare firm held talks to raise EUR200 million of off-balance sheet debt to fund new hospitals.

NMC has come under increased scrutiny from analysts, investors and short-sellers this year about its apparent use of off-balance sheet financing, that does not count toward its official debt levels.

NMC shares dropped on Tuesday after short selling firm Muddy Waters Capital said it had shorted the stock, commenting: "We have serious doubts about the company's financial statements, including its asset values, cash balance, reported profit, and reported debt levels."

NMC on Thursday hit back saying the Muddy Waters report was "false" and "misleading".

NMC shares have almost halved in value this week.

Royal Dutch Shell 'A' and 'B' shares were down 1.2% on Friday, after the oil major guided for a potential impairment based on "the macro outlook".

Shell is to book a post-tax impairment of USD1.7 billion to USD2.3 billion for the fourth-quarter of 2019, based on macroeconomic conditions, without giving any further details. The oil giant, London's largest listed company by market capitalisation, guided for a number of other charges which are set to hit fourth-quarter earnings.

In the Upstream unit, Shell will book USD100 million to USD200 million in charges related to well write-offs, plus a USD500 million to USD600 million deferred tax charge. Production in the segment for the last quarter of 2019 is guided between 2.78 million and 2.83 million barrels of oil equivalent per day. Production in all of 2018 was around 2.7 million barrels a day.

Still to come in the UK corporate calendar, Anglo-US cruise line operator Carnival is expected to report annual earnings this afternoon.

The pound was quoted at USD1.3035 at midday, slightly higher than USD1.3015 late Thursday, after UK economic growth in the third-quarter was revised upwards, the Office for National Statistics revealed.

Third-quarter gross domestic product expanded 0.4% from the second quarter, the ONS said, having previously reported a quarter-on-quarter figure of 0.3%. The ONS also reported a higher annual growth figure, with GDP in the third quarter rising by 1.1% compared to the prior estimate of 1.0%. Services remain the main contributor to growth, the ONS said, with construction also contributing positively.

Meanwhile, the head of the UK financial watchdog Andrew Bailey has been chosen as the next governor of the Bank of England, the Treasury announced.

Bailey's tenure at the BoE will begin on March 16 next year and will succeed Canadian Mark Carney, who took up the role in 2013. Carney has since extended his tenure twice, the second time to avoid any disruption during the UK's talks to leave the EU.

Bailey has been head of the Financial Conduct Authority since July 2016. Before that, he was chief executive of the Prudential Regulation Authority.

As part of his general election pledge to have Brexit "decided" by Christmas, UK Prime Minister Boris Johnson will bring back the EU Withdrawal Agreement Bill for its second reading in the House of Commons on Friday.

After the Conservatives won a landslide at the general election and secured an 80-seat majority last week, the vote in the afternoon is expected to pass without a hitch for the government and lay the ground for a January exit from the EU.

The euro stood at USD1.1094 at midday, down from USD1.1111 late Thursday. Against the yen, the dollar was trading at JPY109.35, firm from JPY109.28 late Thursday.

Stocks in New York were set for a subdued open on Friday. All three major US stock indices set fresh highs on Thursday amid a cooling of US-China trade tensions and a new continental trade agreement among the US, Canada and Mexico advancing in Congress.

The DJIA was called called up 0.1%, the S&P 500 index called flat and the Nasdaq Composite up 0.1%.

Ahead in the economic events calendar, there are US third-quarter GDP figures at 1330 GMT.

Brent oil was quoted at USD66.22 a barrel at the equities close, soft against USD66.50 late Thursday.

Gold was quoted at USD1,477.30 an ounce at the London equities close, little changed USD1,476.20 late Thursday.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

London market Midday is available to subscribers as an email newsletter. Contact info@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.